ATS 2022

COVID-19

SPRINTER: SNG001 still in the running?

Presented By

Dr Philip Monk , Synairgen Research LtD, UK

Trial

Phase 3, SPRINTER

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 14:04

Nebulised aviptadil “futile” in I-SPY COVID-19 trial

Presented By

Prof. Carolyn Calfee, University of California at San Francisco, CA, USA

Trial

Phase 2, I-SPY COVID-19

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 14:01

Lung transplantation after COVID-19-associated ARDS

Presented By

Prof. G.R. Scott Budinger, Northwestern University, IL, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:59

COVI-PRONE trial on its back

Presented By

Prof. Waleed Alhazzani, McMaster University, Canada

Trial

COVI-PRONE

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:57

Mesenchymal stem cells offer no benefit in COVID-19

Presented By

Dr Ellen Gorman, Queen’s University Belfast, UK

Trial

Phase 2, REALIST-COVID

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:55

Alpha-1 antitrypsin for ARDS secondary to severe COVID-19

Presented By

Dr Oliver McElvaney, Royal College of Surgeons, Ireland

Trial

Phase 2

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:53

Frailty prevalent 5 months following hospitalisation for COVID-19

Presented By

Dr Hamish McAuley, University of Leicester, UK

Trial

PHOSP-COVID

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:51

Paediatric long COVID lacks definitions

Presented By

Ms Nadia Baalbaki, Emma Children’s Hospital, the Netherlands

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:49

Asthma Clinical Trial Updates

MANDALA and DENALI pattern success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy & Dr Bradley Chipps, Capital Allergy & Respiratory Disease Center, CA, USA

Trial

Phase 3, MANDALA, DENALI

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:05

ACOUSTICS data sounds good for adolescent asthma exacerbations

Presented By

Prof. Stanley Szefler, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, ACOUSTICS

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:02

Type 2 asthma in children managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:00

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:57

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:55

Chronic Obstructive Pulmonary Disease

Three’s a crowd for triple therapy in COPD

Presented By

Prof. Claus Vogelmeier, Philipps-University Marburg, Germany

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By

Dr Snigdha Jain, Yale School of Medicine, CT, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:39

Reducing dyspnoea in chronic lung disease through weight loss

Presented By

Dr Maria Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:37

CT-evident mucus plugs in COPD associated with death

Presented By

Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA

Trial

COPDGene

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By

Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:33

Highlighted Advances